ATP-P2X7 Receptor Modulates Axon Initial Segment Composition and Function in Physiological Conditions and Brain Injury

Cerebral Cortex

Volumn 25, Issue 8, 2015, Pages 2282-2294

  Del Puerto, Ana ^a,b   Fronzaroli Molinieres, Laure ^e,f   Perez Alvarez, María José ^c   Giraud, Pierre ^e,f   Carlier, Edmond ^e,f   Wandosell, Francisco ^b,d   Debanne, Dominique ^e,f   Garrido, Juan José ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^e INSERM   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

ankyrin G; axon initial segment; BBG; brain ischemia; P2X7 receptor; sodium channels

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANKYRIN; BRILLIANT BLUE; PURINERGIC P2X7 RECEPTOR; VOLTAGE GATED SODIUM CHANNEL; ANK3 PROTEIN, MOUSE; BENZENESULFONIC ACID DERIVATIVE; CALCIUM; CALPAIN; GREEN FLUORESCENT PROTEIN; P2RX7 PROTEIN, MOUSE; P2RX7 PROTEIN, RAT; PURINERGIC P2X RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CALCIUM TRANSPORT; CELL DENSITY; CONTROLLED STUDY; HIPPOCAMPAL NEURONAL CULTURE; MALE; MOUSE; NERVE CELL STIMULATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SODIUM CURRENT; ANIMAL; BRAIN; BRAIN ISCHEMIA; CELL CULTURE; CELL HYPOXIA; DRUG EFFECTS; GENETICS; MEMBRANE POTENTIAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANKYRINS; AXONS; BENZENESULFONATES; BRAIN; BRAIN ISCHEMIA; CALCIUM; CALPAIN; CELL HYPOXIA; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; MALE; MEMBRANE POTENTIALS; MICE; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS, WISTAR; RECEPTORS, PURINERGIC P2X7; TISSUE CULTURE TECHNIQUES; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84938564905     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu035     Document Type: Article

References (58)

1. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H. 2009. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 32:19-29.
2. Arbeloa J, Perez-Samartin A, Gottlieb M, Matute C. 2012. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia. Neurobiol Dis. 45:954-961.
3. Baalman KL, Cotton RJ, Rasband SN, Rasband MN. 2013. Blast wave exposure impairs memory and decreases axon initial segment length. J Neurotrauma. 30:741-751.
4. Bender KJ, Trussell LO. 2012. The physiology of the axon initial segment. Annu Rev Neurosci. 35:249-265.
5. Brater M, Li SN, Gorodezkaya IJ, Andreas K, Ravens U. 1999. Voltagesensitive Ca2+ channels, intracellular Ca2+ stores and Ca2+- release-activated Ca2+ channels contribute to the ATP-induced [Ca2+]i increase in differentiated neuroblastoma × glioma NG 108-15 cells. Neurosci Lett. 264:97-100.
6. Brechet A, Fache MP, Brachet A, Ferracci G, Baude A, Irondelle M, Pereira S, Leterrier C, Dargent B. 2008. Protein kinase CK2 contributes to the organization of sodium channels in axonal membranes by regulating their interactions with ankyrin G. J Cell Biol. 183:1101-1114.
7. Buffington SA, Rasband MN. 2011. The axon initial segment in nervous system disease and injury. Eur J Neurosci. 34:1609-1619.
8. Cario-Toumaniantz C, Loirand G, Ferrier L, Pacaud P. 1998. Non-genomic inhibition of human P2X7 purinoceptor by 17beta-oestradiol. J Physiol. 508(Pt 3):659-666.
9. Cavaliere F, Amadio S, Sancesario G, Bernardi G, Volonte C. 2004. Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J Cereb Blood Flow Metab. 24:392-398.
10. Cruz DA, Weaver CL, Lovallo EM, Melchitzky DS, Lewis DA. 2009. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia. Neuropsychopharmacology. 34:2112-2124.
11. Debanne D, Boudkkazi S, Campanac E, Cudmore RH, Giraud P, Fronzaroli-Molinieres L, Carlier E, Caillard O. 2008. Pairedrecordings from synaptically coupled cortical and hippocampal neurons in acute and cultured brain slices. Nat Protoc. 3:1559-1568.
12. del Puerto A, Diaz-Hernandez JI, Tapia M, Gomez-Villafuertes R, Benitez MJ, Zhang J, Miras-Portugal MT, Wandosell F, Diaz-Hernandez M, Garrido JJ. 2012. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation. J Cell Sci. 125:176-188.
13. Diaz-Hernandez JI, Gomez-Villafuertes R, Leon-Otegui M, Hontecillas- Prieto L, Del Puerto A, Trejo JL, Lucas JJ, Garrido JJ, Gualix J, Miras- Portugal MT et al. 2012. In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases. Neurobiol Aging. 33:1816-1828.
14. Diaz-Hernandez M, del Puerto A, Diaz-Hernandez JI, Diez-Zaera M, Lucas JJ, Garrido JJ, Miras-Portugal MT. 2008. Inhibition of the ATPgated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons. J Cell Sci. 121:3717-3728.
15. Diaz-Hernandez M, Diez-Zaera M, Sanchez-Nogueiro J, Gomez-Villafuertes R, Canals JM, Alberch J, Miras-Portugal MT, Lucas JJ. 2009. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J. 23:1893-1906.
16. Ehrengruber MU, Hennou S, Bueler H, Naim HY, Deglon N, Lundstrom K. 2001. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adenoassociated virus, lentivirus, and measles virus. Mol Cell Neurosci. 17:855-871.
17. Evans MD, Sammons RP, Lebron S, Dumitrescu AS, Watkins TB, Uebele VN, Renger JJ, Grubb MS. 2013. Calcineurin signaling mediates activity-dependent relocation of the axon initial segment. J Neurosci. 33:6950-6963.
18. Franke H, Gunther A, Grosche J, Schmidt R, Rossner S, Reinhardt R, Faber-Zuschratter H, Schneider D, Illes P. 2004. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol. 63:686-699.
19. Friedle SA, Curet MA, Watters JJ. 2010. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov. 5:35-45.
20. Garrido JJ, Giraud P, Carlier E, Fernandes F, Moussif A, Fache MP, Debanne D, Dargent B. 2003. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science. 300: 2091-2094.
21. Grubb MS, Burrone J. 2010. Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability. Nature. 465: 1070-1074.
22. Gutierrez-Martin Y, Bustillo D, Gomez-Villafuertes R, Sanchez-Nogueiro J, Torregrosa-Hetland C, Binz T, Gutierrez LM, Miras-Portugal MT, Artalejo AR. 2011. P2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells. J Biol Chem. 286:11370-11381.
23. Hedstrom KL, Ogawa Y, Rasband MN. 2008. AnkyrinG is required for maintenance of the axon initial segment and neuronal polarity. J Cell Biol. 183:635-640.
24. Hinman JD, Rasband MN, Carmichael ST. 2013. Remodeling of the axon initial segment after focal cortical and white matter stroke. Stroke. 44:182-189.
25. Hwang SM, Li J, Koo NY, Choi SY, Lee SJ, Oh SB, Castro R, Kim JS, Park K. 2009. Role of purinergic receptor in alpha fodrin degradation in Par C5 cells. J Dent Res. 88:927-932.
26. Jiang LH, Baldwin JM, Roger S, Baldwin SA. 2013. Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front Pharmacol. 4:55.
27. Jiang LH, Mackenzie AB, North RA, Surprenant A. 2000. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol. 58:82-88.
28. Jo S, Bean BP. 2011. Inhibition of neuronal voltage-gated sodium channels by brilliant blue G. Mol Pharmacol. 80:247-257.
29. Kaech S, Banker G. 2006. Culturing hippocampal neurons. Nat Protoc. 1:2406-2415.
30. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL, Hayes RL. 1996. Mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem. 67:1575-1583.
31. Kaphzan H, Buffington SA, Jung JI, Rasband MN, Klann E. 2011. Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome. J Neurosci. 31:17637-17648.
32. Kim JE, Kwak SE, Jo SM, Kang TC. 2009. Blockade of P2X receptor prevents astroglial death in the dentate gyrus following pilocarpine-induced status epilepticus. Neurol Res. 31:982-988.
33. Kimbler DE, Shields J, Yanasak N, Vender JR, Dhandapani KM. 2012. Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS One. 7:e41229.
34. Kole MH, Ilschner SU, Kampa BM, Williams SR, Ruben PC, Stuart GJ. 2008. Action potential generation requires a high sodium channel density in the axon initial segment. Nat Neurosci. 11:178-186.
35. Kuba H, Oichi Y, Ohmori H. 2010. Presynaptic activity regulates Na(+) channel distribution at the axon initial segment. Nature. 465: 1075-1078.
36. Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84-91.
37. Matute C, Torre I, Perez-Cerda F, Perez-Samartin A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodriguez-Antiguedad A, Sanchez- Gomez M et al. 2007. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci. 27:9525-9533.
38. Melani A, Corti F, Stephan H, Muller CE, Donati C, Bruni P, Vannucchi MG, Pedata F. 2012. Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic in vivo conditions in the rat striatum. Exp Neurol. 233:193-204.
39. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F. 2005. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int. 47:442-448.
40. Nishida K,Nakatani T, Ohishi A, OkudaH, HigashiY,Matsuo T, Fujimoto S, Nagasawa K. 2012. Mitochondrial dysfunction is involved in P2X7 receptor-mediated neuronal cell death. J Neurochem. 122:1118-1128.
41. North RA, Surprenant A. 2000. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 40:563-580.
42. Ogawa Y, Horresh I, Trimmer JS, Bredt DS, Peles E, Rasband MN. 2008. Postsynaptic density-93 clusters Kv1 channels at axon initial segments independently of Caspr2. J Neurosci. 28:5731-5739.
43. Pan Z, Kao T, Horvath Z, Lemos J, Sul JY, Cranstoun SD, Bennett V, Scherer SS, Cooper EC. 2006. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci. 26:2599-2613.
44. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R. 2003. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem. 278:13309-13317.
45. Perez-Alvarez MJ, Maza Mdel C, Anton M, Ordonez L, Wandosell F. 2012. Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J Neuroinflammation. 9:157.
46. Ray SK, Hogan EL, Banik NL. 2003. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 42:169-185.
47. Sanchez-Ponce D, Munoz A, Garrido JJ. 2011. Casein kinase 2 and microtubules control axon initial segment formation. Mol Cell Neurosci. 46:222-234.
48. Schafer DP, Jha S, Liu F, Akella T, McCullough LD, Rasband MN. 2009. Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury. J Neurosci. 29:13242-13254.
49. Tapia M, Del Puerto A, Puime A, Sanchez-Ponce D, Fronzaroli- Molinieres L, Pallas-Bazarra N, Carlier E, Giraud P, Debanne D, Wandosell F et al. 2013. GSK3 and beta-catenin determines functional expression of sodium channels at the axon initial segment. Cell Mol Life Sci. 70:105-120.
50. Vacher H, Yang JW, Cerda O, Autillo-Touati A, Dargent B, Trimmer JS. 2011. Cdk-mediated phosphorylation of the Kvbeta2 auxiliary subunit regulates Kv1 channel axonal targeting. J Cell Biol. 192:813-824.
51. Vianna EP, Ferreira AT, Naffah-Mazzacoratti MG, Sanabria ER, Funke M, Cavalheiro EA, Fernandes MJ. 2002. Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43(Suppl 5):227-229.
52. von Reyn CR, Spaethling JM, Mesfin MN, Ma M, Neumar RW, Smith DH, Siman R, Meaney DF. 2009. Calpain mediates proteolysis of the voltage-gated sodium channel alpha-subunit. J Neurosci. 29: 10350-10356.
53. Vosler PS, Brennan CS, Chen J. 2008. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol. 38:78-100.
54. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA et al. 2004. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med. 10:821-827.
55. Wirkner K, Kofalvi A, Fischer W, Gunther A, Franke H, Groger-Arndt H, Norenberg W, Madarasz E, Vizi ES, Schneider D et al. 2005. Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem. 95:1421-1437.
56. Yrjanheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Hull M, Fiebich BL. 2005. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res. 1052:174-179.
57. Zhang M, Li W, Niu G, Leak RK, Chen J, Zhang F. 2013. ATP induces mild hypothermia in rats but has a strikingly detrimental impact on focal cerebral ischemia. J Cereb Blood Flow Metab. 33:1-10.
58. Zheng W, Watts LT, Holstein DM, Prajapati SI, Keller C, Grass EH, Walter CA, Lechleiter JD. 2010. Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One. 5: e14401.